Literature DB >> 22228905

Colorectal cancer staging using TNM 7: is it time to use this new staging system?

V J Doyle1, A C Bateman.   

Abstract

The authors audited pathological colorectal cancer staging according to tumour node metastasis (TNM) 7 and using TNM 5 as a gold standard. 144 consecutive colorectal cancer resection specimens were staged prospectively using both TNM 5 and TNM 7 criteria during routine reporting by specialist gastrointestinal pathologists within a single institution. The pN stage remained the same under both systems apart from the required subclassification of pN1 and pN2 under TNM 7. The TNM 7 pN1c category was used in only 3% of cases. All cases staged as pT4 underwent reversal of pT4 subclassification using TNM 7 compared with TNM 5. A previous study revealed stage migration from pN1 to pN2 in 32.6% of cases under TNM 7 compared with TNM 5. The difference in frequency of pN stage migration between this study and our audit suggests that the application of TNM 7 to the assessment of discontinuous/satellite tumour foci is subject to significant inter-observer variability.

Entities:  

Mesh:

Year:  2012        PMID: 22228905     DOI: 10.1136/jclinpath-2011-200503

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Proposal of a new classification for stage III colorectal cancer based on the number and ratio of metastatic lymph nodes.

Authors:  Li-Ping Wang; Hong-Yan Wang; Rui Cao; Cong Zhu; Xiong-Zhi Wu
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

2.  Deriving stage at diagnosis from multiple population-based sources: colorectal and lung cancer in England.

Authors:  S Benitez-Majano; H Fowler; C Maringe; C Di Girolamo; B Rachet
Journal:  Br J Cancer       Date:  2016-06-21       Impact factor: 7.640

3.  Pair-wise comparison analysis of differential expression of mRNAs in early and advanced stage primary colorectal adenocarcinomas.

Authors:  Tze Pheng Lau; April Camilla Roslani; Lay Hoong Lian; Hwa Chia Chai; Ping Chin Lee; Ida Hilmi; Khean Lee Goh; Kek Heng Chua
Journal:  BMJ Open       Date:  2014-08-08       Impact factor: 2.692

4.  TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas.

Authors:  Francesca Maddalena; Valentina Condelli; Danilo Swann Matassa; Consiglia Pacelli; Rosella Scrima; Giacomo Lettini; Valeria Li Bergolis; Michele Pietrafesa; Fabiana Crispo; Annamaria Piscazzi; Giovanni Storto; Nazzareno Capitanio; Franca Esposito; Matteo Landriscina
Journal:  Mol Oncol       Date:  2020-10-30       Impact factor: 6.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.